Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Investigational anticonvulsant increases high-voltage sleep

June 29, 2006

Sustained quality of life gains seen with rotigotine in restless legs syndrome

June 29, 2006

Exelon, first FDA approved treatment for Parkinson's disease dementia

June 28, 2006

Merck, Sharp & Dohme report on new GABA-A alpha3 modulators

June 28, 2006

Studies delineate armodafinil effects in patients with sleep disorders

June 28, 2006

Cyclohexanehexol Abeta inhibitors from Transition Therapeutics improve cognition in vivo

June 27, 2006

New agents for neurological disorders subject of recent patents

June 27, 2006

Inhibition of FAAH modulates sleep patterns by increasing brain endocannabinoids

June 27, 2006

Phase III studies of sarizotan fail to meet primary efficacy endpoint

June 27, 2006

AV-650 cleared to begin U.S. clinical trials

June 27, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 7, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 7, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.